Glenmark Pharmaceuti Dividend yield report




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   INR per share 
 Price  598.30
 Dividend  1.97
 Earnings  46.74
 Cash-flow  17.44
 Book value  157.45
 Equity  155.28

Glenmark Pharmaceuti is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Glenmark Pharmaceuti is a company from India, and his stocks are publicly traded.

Glenmark Pharmaceuti paid a total dividend of 556 million INR last year, for a market value of 168,721 millions (Market Cap 82,722 millions). Dividend per share of Glenmark Pharmaceuti is 1.97 INR, and his stock market price 598.30 INR.

According to the chart below, where dividend yield is displayed, Glenmark Pharmaceuti has a dividend yield of 0.33%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

Dividend yield of Glenmark Pharmaceuti

About the ability of Glenmark Pharmaceuti to maintain his current dividend of INR 1.97 per share, an amount that accounts for 0.33%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Glenmark Pharmaceuti payout on ernings is currently 4.21%, which is lower than the market average and companies of Health Care industry, which are 38.92% and 30.76% respectively. Both figures lead us to believe that there is confidence that Glenmark Pharmaceutican maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Glenmark Pharmaceuti is INR 17.44 per share, which is higher than the dividend per share paid by the company of INR 1.97, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Glenmark Pharmaceuti, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of Glenmark Pharmaceuti.

Then, you should compare Glenmark Pharmaceuti dividend yield with other Pharmaceuticals and Biotechnology companies or firms from India.

Glenmark Pharmaceuti payout

Finally, last moth Glenmark Pharmaceuti showed a return of -1.80% compared to a worldwide 1.54% average, and a 1.00% of Health Care firms. Over the last year, the company obtained a -35.20% versus a worldwide performance of a 18.74%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.

Glenmark Pharmaceuti stock and market return

Next companies

Global Brands Group. Hong-Kong. Consumer Goods.
Global Logistic Prop. Singapore. Financials.
Global Mediacom Tbk. Indonesia. Consumer Services.
Global Payments Inc. USA. Industrials.
Global Telecom Holdi. Egypt. Telecommunications.
Globe Telecom. Philippines. Telecommunications.

Previous companies

Glencore. UK. Basic Materials.
GlaxoSmithKlinensume. India. Consumer Goods.
GlaxoSmithKline Phar. India. Health Care.
GlaxoSmithKline. UK. Health Care.
Glanbia. Ireland. Consumer Goods.
GKN. UK. Consumer Goods.

 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.